Home › Waldenstrom Macroglobulinemia › Colorado › Denver
Waldenstrom Macroglobulinemia clinical trials in Denver, CO
7 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
RecruitingPhase 2
- Colorado Blood Cancer Institute (CBCI), Denver
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Dallas, TX6 studies
- New York City, NY6 studies
- Edison, NJ6 studies
- Houston, TX6 studies
- Columbus, OH5 studies
- Seattle, WA5 studies
- Rochester, MN5 studies
- Milwaukee, WI5 studies
- Queens, NY4 studies
- Baldwin Park, CA4 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.